Teva Pharmaceuticals USA Issues Statement on Affordable Medicines Utilization Act of 2011

NORTH WALES, Pa.--(BUSINESS WIRE)-- Teva commends Senators Scott Brown, Ron Wyden and John McCain for introducing the Affordable Medicines Utilization Act of 2011. As the largest provider of generic pharmaceuticals in the United States, Teva has been and continues to be committed to providing patients with access to the life-saving medicines they need. This legislation will encourage States to increase access to high-quality, low-cost pharmaceuticals for their Medicaid populations. At a time when State government officials are struggling to close their budget shortfalls, improving access to FDA approved generic medicines will help lower their health care costs while maintaining access to care.



CONTACT:

Teva Pharmaceuticals
Denise Bradley, 215-591-8974
[email protected]

KEYWORDS:   United States  North America  Pennsylvania

INDUSTRY KEYWORDS:   Health  Public Policy/Government  Healthcare Reform  Pharmaceutical

MEDIA:

Suggested Articles

Astellas and Seattle Genetics are out with Padcev-Keytruda combo data that may be good enough to snag an expedited regulatory review, analysts say.

Distributors had offered billions of dollars to wrap up opioid litigation, but that effort has suffered a major setback, WSJ reports.

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.